The future of pharmacy starts here.


At the Skaggs School of Pharmacy, students from around the globe learn from award-winning faculty in a world-class medical setting. Hands-on training is dynamic, interprofessional and career-driven. From our entry-level PharmD program to flexible online degrees, our curriculum is innovative and agile, preparing students to be leaders in the emerging pharmacy careers of the future.

Hispanic Serving Institute

Explore Our Programs


PharmD Program

Interprofessional and experiential. From hospitals and industry settings, to clinics and pharmacies, our PharmD graduates are taking the lead optimizing medications and improving patient care.


Online Programs

We’ve been offering online degrees for more than 20 years. And it shows. Our online degrees and certificates deliver academic rigor in a flexible, interactive setting.


Master's Programs

Whether it’s a Master’s in Clinical Pharmacy, Pharmaceutical Sciences, or Palliative Care, adding an MS to your toolkit will deepen your patient-centered skills and increase your professional opportunities.


PhD Programs

Ready to create the next antiviral drug or develop an algorithm to make prescription costs more accessible? If so, one of our three diverse PhD programs can help elevate your impact.

Vaccination Efforts

Continuing Education

Ready to take your career a step further? With our continuing education programs, you can expect to learn from top experts in trending health topics.

Top 15% of pharmacy schools

Top 10% in NIH funding

91% first-time NAPLEX pass rate

More than 1,300 rotation sites

95% of grads employed within 6 months

7 ACCP national award winners

Explore Our Campus


Learn on an Interprofessional Team

From the first week on campus, you’ll engage in experiential and interprofessional training that prepares you for team-based pharmacy careers.


See How We Come Together

Every challenge requires teamwork. This pandemic is no different. Good thing we’re used to rising to the occasion – together.


View the Campus for Yourself

We can’t wait until we can welcome you to campus. But for now, take a 360 virtual tour of our 256-acre medical campus.


Upcoming Events


Eight Things You Should Know About Omicron

Omicron cases are rising at staggering rates worldwide, and Colorado, once again, stands out as a national hotspot. CU experts Krishna Mallela, PhD and Ross Kedl, PhD try to answer questions as the world of COVID turns.


New Research Could Anticipate Covid’s Next Move

Dr. Krishna Mallela and his team, Dr. Vaibhav Upadhyay, PhD, and PhD student Alexandra Lucas, are working to identify new COVID-19 variants, before the virus can mutate itself. 


P4’S Research Lands her National Fellowship and Faculty Admiration

P4 Madison Ricco combines her love of research with clinical practice, and won a Gateway to Research Award in the process.


The Class of 2024 Displays its Resilience Through Annual Story Slam

The class of 2024 participated in the annual Story Slam - a year later, and a year wiser, because of the pandemic.


Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.


How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.


Covid pills are ‘very promising’ – but what are the challenges in using them?

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.


US, NGO combat cancer, train 34 Nigerian oncology pharmacists

Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.